18 Feb 2020 --- Non-alcoholic fatty liver disease (NAFLD) and its subtype non-alcoholic steatohepatitis (NASH) affect approximately 30 percent and 5 percent, respectively, of the US population, according to the American Liver Foundation. As these numbers continue to soar, the conclusions of a new US mice study indicate that a combination of green tea extract and exercise may provide a novel avenue for research on fatty liver disease. Meanwhile, Canadian research has highlighted the central role vitamin E supplementation may play in treating NASH in HIV-infected patients. NutritionInsight investigates the current groundwork laid in this field and what potential it holds for NAFLD and NASH treatment.
